
0:00
47:44
Dr. David Katz, President and CEO of Diet ID, joins Double Take to examine how GLP-1s may affect far more than weight loss—from food noise and addiction to healthcare costs, side effects and shifts in consumer behavior across sectors.
Mais episódios de "Double Take By BNY Investments"



Não percas um episódio de “Double Take By BNY Investments” e subscrevê-lo na aplicação GetPodcast.








